Multiple Myeloma Patient Care by an 100% Oncology Focused Pharmacy for

Compassionate Oncology Pharmacy Care for Multiple Myeloma Patients

March is Multiple Myeloma Awareness Month, and we are your partner for compassionate multiple myeloma specialty pharmacy care. We have access to many treatment options and offer expert clinical services, personalized programs, and are available 24/7.

Facts and Stats for Multiple Myeloma

Causes an overgrowth of plasma cells in the bone marrow and can crowd out normal blood-forming cells, leading to low blood counts.
According to the American Cancer Society, about 36,000 new cases will be diagnosed in 2026.
A person’s lifetime risk is 1 in 108 for men and about 1 in 133 for women.¹

Why Choose Onco360?

As a specialty pharmacy 100% focused on cancer, we will act as your advocate with your physician, insurance company, and others involved in your treatment.
Timing is crucial when it comes to cancer treatment. Our goal, without prior authorization or funding issues, is to have your medication delivered within 3-4 days. We even provide complimentary overnight shipping to your doorstep.
Our OncoAdvocate^® Team explores funding options for qualified patients quickly with our proprietary Funding FastTrack program.
We will make sure you understand your medications, their dosage, and any potential side effects. Our clinicians are on call 24/7 if you have any questions at 877.662.6633.

In 2025, our OncoAdvocate^® Team
sourced $67+ million in funding for
our multiple myeloma patients

Currently, more than 87% of multiple
myeloma patient’s copays are covered
by funding sources or copay cards

91% of our multiple myeloma
patients paid less than $25
on their last dispense

Onco360 dispenses these medications to treat multiple myeloma^**

Alkeran^® (melphalan)
Adriamycin^® (doxorubicin)
Belrapzo^®, Bendeka®, Treanda® (bendamustine)
Cytoxan^® (cyclophosphamide)
Darzalex^® (daratumumab)
Decadron^® (dexamethasone)
Deltasone^® (prednisone)
Elrexfio^™ (elranatamab-bcmm)
Empliciti^® (elotuzumab)
Evomela^® (melphalan)
Kyprolis^® (carfilzomib)
Lynozyfic^™ (linvoseltamab-gcpt)

Ninlaro^® (ixazomib)
Platinol^® (cisplatin)
Pomalyst^® (pomalidomide)
Revlimid^® (lenalidomide)
Talvey^® (talquetamab-tgvs)
Tecvayli^® (teclistamab-cqyv)
Thalomid^® (thalidomide)
Toposar^® (etoposide)
Velcade^® (bortezomib)
Venclexta^® (venetoclax)
Xpovio^® (selinexor)

^**This list is a small portion of the comprehensive medications Onco360 can provide.

Multiple Myeloma Research Foundation (MMRF)

Providing Patient and Caregiver Education with the Multiple Myeloma Research Foundation During Multiple Myeloma Awareness Month and Beyond

We have partnered with the Multiple Myeloma Research Foundation (MMRF) to help empower patients and caregivers with knowledge, resources, and support to make more informed decisions about their care. The MMRF creates and distributes Patient Toolkits that are filled with over 50 topics to help multiple myeloma patients confidently navigate their journey. Because our mission is to improve the lives of patients battling cancer, we have sponsored 3,500 Toolkits that will be distributed throughout the year.

For more information:

MMRF PATIENT TOOLKITS